Everything You Need to Know: Pfizer, Bristol-Myers Squibb, VIVUS, Sarepta, and St. Jude

By Dave Williamson and Brenton Flynn – Nov 22, 2012 at 5:00PM

NYSE: PFE

Pfizer

Market Cap

$144B

Today's Change

(-1.05%) -$0.27

Current Price

$25.42

Price as of April 17, 2024, 4:00 p.m. ET

Motley Fool analyst David Williamson takes us through some major health-care jumps and tumbles.

In this video, Motley Fool health-care analyst David Williamson talks about some of the biggest investing stories in the health-care space today. He tells us about Pfizer (NYSE: PFE) and Bristol-Myers Squibb's (NYSE: BMY) latest European victory, a major insurance win for obesity-drug maker VIVUS (NASDAQ:VVUS), a huge vote of share-price confidence for Sarepta (NASDAQ: SRPT) and its drug for Duchenne muscular dystrophy, and a big tumble for St. Jude Medical (NYSE: STJ) after another problem with one of its products.

Brenton Flynn owns shares of Sarepta Therapeutics. David Williamson owns shares of Pfizer. The Motley Fool owns shares of St. Jude Medical. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.